Skip to main content

Mereo BioPharma Group plc (NASDAQ: MREO) Investor Securities Class Action Lawsuit 02/04/2026

  • If you purchased a significant amount of shares of Mereo BioPharma Group plc (NASDAQ: MREO) between June 5, 2023, and December 26, 2025, and / or if you purchased any NASDAQ: MREO shares prior to June 2023 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: April 6, 2026. NASDAQ: MREO investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

February 04, 2026 - An investor in shares of Mereo BioPharma Group plc (NASDAQ: MREO) filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Mereo BioPharma Group plc connection with certain allegedly false and misleading statements made between June 5, 2023, and December 26, 2025.   London based Mereo Bio...



You must register (for free) or login to view the entire case.